5 Active Studies

Myositis Clinical Trials

Find actively recruiting research studies for myositis. Connect with study sites near you and explore new treatment options.

5
Active Trials
37+
Locations
916
Participants Needed

Recruiting Studies

RecruitingNCT05895786

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

The purpose of the study is to understand how the study medicine PF-06823859 works in people with idiopathic inflammatory myopathies (DM and PM). These disorders cause inflammation that weakens the mu...

10 locations(Glendale, Glendale, Phoenix)
318 participants
Pfizer
View Study Details
RecruitingNCT06455449

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

The purpose of this multicenter, randomized, placebo-controlled and double-blind study is to evaluate the efficacy and safety of subcutaneous anifrolumab compared with placebo on the overall disease a...

10 locations(Irvine, Aurora, Denver)
240 participants
AstraZeneca
View Study Details
RecruitingNCT06698796

A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

The purpose of this study is to understand how the study medicine, dazukibart, works in people with active idiopathic inflammatory myopathies (dermatomyositis \[DM\] or polymyositis \[PM\]). Idiopath...

9 locations(Glendale, Beckley, Plovdiv)
211 participants
Pfizer
View Study Details
RecruitingNCT06665256

Phase 2 Study of Rapcabtagene Autoleucel in Myositis

A Phase 2, randomized, open-label, controlled study to evaluate the efficacy and safety of rapcabtagene autoleucel versus comparator in participants with severe refractory idiopathic inflammatory myop...

10 locations(Chicago, Iowa City, Salt Lake City)
123 participants
Novartis Pharmaceuticals
View Study Details
RecruitingNCT06154252

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy...

10 locations(Orange, San Francisco, Aurora)
24 participants
Cabaletta Bio
View Study Details

Frequently Asked Questions

What clinical trials are available for Myositis?

There are currently 5 actively recruiting clinical trials for myositis. These studies are testing new treatments, therapies, and interventions at research sites across 37 cities.

How do I join a Myositis clinical trial?

To join a myositis clinical trial: 1) Browse the available studies above, 2) Click on a study that interests you, 3) Complete the eligibility form, and 4) A study coordinator will contact you.

Are clinical trials free for patients?

Yes, clinical trial participation is free. In most studies, the treatment, medical tests, and doctor visits related to the trial are provided at no cost. Some studies may also compensate for time and travel.

Can I leave a clinical trial if I change my mind?

Yes, participation in any clinical trial is completely voluntary. You can withdraw at any time, for any reason, without affecting your regular medical care.